Thallium, Blood
Oncomine™ Dx Target Test
Brompheniramine
Gastrointestinal Parasite Pathogen Panel, Molecular
Acute pain
Malignant neoplasm, female breast
Obstruction of bile duct
Estrogen/Progesterone Receptor, IHC, Semi-Quantitative
Thioridazine, Urine
Calcium Sensing Receptor (CASR) Gene Mutation Analysis
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
LOINC
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now